P039: Neuropsychiatric symptom burden of cerebrotendinous xanthomatosis, the importance of diagnosing early, and the impact of CDCA treatment: A US-based survey
Cerebrotendinous xanthomatosis (CTX) is a rare, autosomal recessive metabolic disorder of bile acid synthesis resulting in a pathological storage of lipids throughout body tissues. This leads to early-onset chronic diarrhea, juvenile-onset bilateral cataracts, tendon xanthomas, and progressive neurological deterioration. These debilitating symptoms underscore the need to diagnose CTX early in order to limit serious neuropsychiatric and physical disability. There is a paucity of data in the literature focused on the burden and severity of neurologic and psychiatric symptoms associated with CTX.
Authors
- Pamela Vig (ORCID: https://orcid.org/0009-0000-4226-5435)
- Florian Eichler (ORCID: https://orcid.org/0000-0001-6836-1089)
- Graham Bryce (ORCID: https://orcid.org/0000-0001-9948-8066)
- C. Pernia Higuera
- Jolan Terner-Rosenthal
- Brian D. Wishart
- Tiziano Pramparo (ORCID: https://orcid.org/0000-0001-6929-1027)
- Raúl Aguilar Ruíz (ORCID: https://orcid.org/0000-0002-0541-4910)
- Neel Odedara
- Shawn Laurie
- Bobbi Blanchard
- Rana Dutta
- Jean Pickford
Institutions
- Harvard University (US)
- Tennessee Orthopaedic Alliance (US)
Publication Details
- Journal
- Genetics in Medicine Open
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gimo.2025.102883
- Primary Topic
- Cholesterol and Lipid Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00